IP Library Assignment 061735/0875
Patent Assignment
Reel/Frame 061735/0875

Patent Security Agreement

Recorded: 2022-10-20 Pages: 32
Assignor
INSMED INCORPORATED
Executed: 2022-10-19
Assignee
BIOPHARMA CREDIT PLC
C/O BEAUFORT HOUSE, 51 NEW NORTH ROAD, EXETER EX4 4EP, UNITED KINGDOM
Covered Properties (111)
Pharmaceutical Formulations of Treprostinil Prodrugs and Methods of Use Thereof
Methods for Extracting Neutrophil Serine Proteases and Treating Dipeptidyl Peptidase 1-Mediated Conditions
Methods for Treating Newly Diagnosed Mycobacterium Avium Complex Lung Infections
Dry Powder Compositions of Treprostinil Prodrugs and Methods of Use Thereof
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides for Treating Behaceta's Disease
Dry Powder Compositions of Glycopeptide Derivative Compounds and Methods of Use Thereof
Combination Therapy for Treating Non-Tuberculous Mycobacterial Lung Disease
Certain N-(1-Cyano-2-Phenylethyl)-1,4-Oxazepane-2-Carboxamides for Treating Cancer
Certain N-(1-Cyano-2-Phenylethyl)-1,4-Oxazepane-2-Carboxamides for Treating Cystic Fibrosis
In Vitro Release Assay Methods for Liposomal Aminoglycoside Formulations
Tunable Polymeric Nanoparticles for Targeted and Sustained Delivery of Glycopeptide Antibiotics
Adeno-Associated Virus Particles and Methods of Use Thereof
Fluid Droplet Production Apparatus and Method
Patent: 7,931,212 →
Application: 10/522,344 →
Publication: US 2006/0097068
Inhalation Therapy Device
Patent: 7,458,372 →
Application: 10/533,430 →
Publication: US 2006/0102172
Inhalation Therapy Device
Patent: 9,061,303 →
Application: 10/538,515 →
Publication: US 2008/0060640
Sustained Release of Antiinfectives
Patent: 7,544,369 →
Application: 10/696,389 →
Publication: US 2004/0142026
Method for Use of Igf-Binding Protein for Selective Sensitization of Target Cells in Vivo
Patent: 7,371,813 →
Application: 10/778,636 →
Publication: US 2006/0029606
Device for Inhalation Therapy
Patent: 7,252,085 →
Application: 10/810,098 →
Publication: US 2005/0056274
Recombinant Igf Expression Systems
Patent: 7,354,994 →
Application: 10/866,086 →
Publication: US 2005/0095672
Sustained Release of Antiinfectives
Patent: 7,718,189 →
Application: 11/185,448 →
Publication: US 2006/0073198
Purified Rhlgf-I/Rhlgfbp-3 Complexes and Their Method of Manufacture
Patent: 7,968,679 →
Application: 11/311,633 →
Publication: US 2006/0166884
Lipid-Based Compositions of Antiinfectives for Treating Pulmonary Infections and Methods of Use Thereof
Patent: 8,226,975 →
Application: 11/634,343 →
Publication: US 2007/0196461
Methods of Treating Pulmonary Disorders with Liposomal Amikacin Formulations
Patent: 9,114,081 →
Application: 12/250,412 →
Publication: US 2009/0104256
Sustained Release of Antiinfectives
Patent: 8,802,137 →
Application: 12/748,756 →
Publication: US 2010/0260829
Fluid Droplet Production Apparatus and Method
Patent: 8,511,581 →
Application: 13/042,980 →
Publication: US 2011/0155768
Therapeutic Charge Engineered Variants of Lysozyme and Methods for Using The Same to Treat Infections
Patent: 9,074,201 →
Application: 13/144,553 →
Publication: US 2013/0058912
Method of Treating Pulmonary Disorders with Liposomal Amikacin Formulations
Patent: 9,119,783 →
Application: 13/480,246 →
Publication: US 2013/0089598
Lipid-Based Compositions of Antiinfectives for Treating Pulmonary Infections and Methods of Use Thereof
Patent: 8,632,804 →
Application: 13/527,213 →
Publication: US 2013/0028960
Method for Treating Pulmonary Disorders with Liposomal Amikacin Formulations
Patent: 9,333,214 →
Application: 13/566,707 →
Publication: US 2013/0136788
Lipid-Based Compositions of Antiinfectives for Treating Pulmonary Infections and Methods of Use Thereof
Patent: 8,679,532 →
Application: 13/664,181 →
Publication: US 2013/0052260
Lipid-Based Compositions of Antiinfectives for Treating Pulmonary Infections and Methods of Use Thereof
Patent: 8,642,075 →
Application: 13/666,420 →
Publication: US 2013/0064883
Lipid-Based Compositions of Antiinfectives for Treating Pulmonary Infections and Methods of Use Thereof
Patent: 8,673,348 →
Application: 13/675,559 →
Publication: US 2013/0071468
Lipid-Based Compositions of Antiinfectives for Treating Pulmonary Infections and Methods of Use Thereof
Patent: 8,673,349 →
Application: 13/675,587 →
Publication: US 2013/0071469
Systems for Treating Pulmonary Infections
Patent: 9,566,234 →
Application: 13/899,457 →
Publication: US 2013/0330400
Aerosol Generator
Patent: 9,975,136 →
Application: 14/123,634 →
Publication: US 2014/0263721
Sustained Release of Antiinfectives
Patent: 9,827,317 →
Application: 14/319,018 →
Publication: US 2014/0314835
Prostacyclin Compounds, Compositions and Methods of Use Thereof
Patent: 9,469,600 →
Application: 14/523,538 →
Publication: US 2015/0148414
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Patent: 9,522,894 →
Application: 14/601,371 →
Publication: US 2015/0210655
Prostacyclin Compounds, Compositions and Methods of Use Thereof
Patent: 9,255,064 →
Application: 14/641,104 →
Publication: US 2015/0175529
Methods for Treating Pulmonary Non-Tuberculous Mycobacterial Infections
Patent: 9,895,385 →
Application: 14/713,926 →
Publication: US 2015/0328244
Therapeutic Charge Engineered Variants of Lysozyme and Methods for Using Same to Treat Infections
Patent: 9,950,041 →
Application: 14/791,979 →
Publication: US 2017/0128546
Methods of Treating Pulmonary Disorders with Liposomal Amikacin Formulations
Patent: 9,724,301 →
Application: 14/809,127 →
Publication: US 2016/0143849
Method of Treating Pulmonary Disorders with Liposomal Amikacin Formulations
Patent: 9,737,555 →
Application: 14/809,128 →
Publication: US 2016/0151402
Unglycosylated Lysostaphin Variant Protein
Application: 14/907,746 →
Publication: US 2016/0168556
Lipid-Based Compositions of Antiinfectives for Treating Pulmonary Infections and Methods of Use Thereof
Patent: 9,402,845 →
Application: 14/987,508 →
Publication: US 2016/0113927
Prostacyclin Compounds, Compositions and Methods of use Thereof
Application: 15/154,631 →
Publication: US 2016/0256425
Lipid-Based Compositions of Antiinfectives for Treating Pulmonary Infections and Methods of Use Thereof
Patent: 9,511,082 →
Application: 15/205,918 →
Publication: US 2016/0317563
Lipid-Based Compositions of Antiinfectives for Treating Pulmonary Infections and Methods of Use Thereof
Patent: 9,549,939 →
Application: 15/205,925 →
Publication: US 2016/0317564
Lipid-Based Compositions of Antiinfectives for Treating Pulmonary Infections and Methods of Use Thereof
Patent: 9,549,925 →
Application: 15/241,439 →
Publication: US 2016/0354371
Methods for Treating Pulmonary Non-Tuberculous Mycobacterial Infections
Application: 15/311,488 →
Publication: US 2017/0360816
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Patent: 9,815,805 →
Application: 15/346,411 →
Publication: US 2017/0057938
Lipid-Based Compositions of Antiinfectives for Treating Pulmonary Infections and Methods of Use Thereof
Application: 15/376,086 →
Publication: US 2017/0087155
Methods of Manufacturing Treprostinil and Treprostinil Derivative Prodrugs
Application: 15/527,811 →
Publication: US 2017/0320813
Methods of Treating Pulmonary Disorders with Liposomal Amikacin Formulations
Application: 15/638,548 →
Publication: US 2017/0360818
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Application: 15/708,634 →
Publication: US 2018/0251436
Novel Prodrug Salts
Application: 15/792,707 →
Publication: US 2018/0169118
Aerosol Generator
Application: 15/955,973 →
Publication: US 2018/0236478
Prostacyclin Compounds, Compositions and Methods of Use Thereof
Application: 15/994,574 →
Publication: US 2019/0248731
Methods for Treating Pulmonary Non-Tuberculous Mycobacterial Infections
Application: 16/007,075 →
Publication: US 2018/0311267
Methods for Treating Pulmonary Non-Tuberculous Mycobacterial Infections
Application: 16/250,476 →
Publication: US 2019/0216834
Methods for Treating Pulmonary Non-Tuberculous Mycobacterial Infections
Application: 16/263,648 →
Publication: US 2019/0160086
Antibodies and Methods of Making Same
Application: 16/303,530 →
Publication: US 2020/0317792
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Application: 16/358,091 →
Publication: US 2020/0017455
Methods of Manufacturing Treprostinil and Treprostinil Derivative Prodrugs
Application: 16/417,958 →
Publication: US 2019/0337888
Deimmunized Lysostaphin and Methods of Use
Application: 16/432,246 →
Publication: US 2020/0040321
Methods for Treating Pulmonary Non-Tuberculous Mycobacterial Infections
Application: 16/515,303 →
Publication: US 2020/0009171
Lipo-Glycopeptide Cleavable Derivatives and Uses Thereof
Application: 16/615,214 →
Publication: US 2020/0155640
Glycopeptide Derivative Compounds and Uses Thereof
Application: 16/615,232 →
Publication: US 2020/0368312
Prostacyclin Compounds, Compositions and Methods of Use Thereof
Application: 16/685,751 →
Publication: US 2020/0079724
Lipid-Based Compositions of Antiinfectives for Treating Pulmonary Infections and Methods of Use Thereof
Application: 16/746,205 →
Publication: US 2020/0390758
Methods for Treating Pulmonary Non-Tuberculous Mycobacterial Infections
Application: 16/778,506 →
Publication: US 2020/0268781
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Application: 16/855,522 →
Publication: US 2020/0247765
Dry Powder Compositions of Treprostinil Prodrugs and Methods of Use Thereof
Application: 16/860,428 →
Publication: US 2020/0338005
Methods for Treating Pulmonary Non-Tuberculous Mycobacterial Infections
Application: 16/930,134 →
Publication: US 2020/0345754
PHARMACEUTICAL COMPOSITIONS COMPRISING (2S)-N-{(1S)-1-CYANO-2-[4-(3-METHYL-2-OXO-2,3-DIHYDRO-1,3-BENZOXAZOL-5-yl)PHENYL]ETHYL}-1,4-OXAZEPANE-2-CARBOXAMIDE
Application: 16/975,292 →
Publication: US 2021/0369732
Methods for Continuous Manufacture of Liposomal Drug Products
Application: 16/981,149 →
Publication: US 2021/0015750
Methods for Treating Pulmonary Non-Tuberculous Mycobacterial Infections
Application: 17/031,744 →
Publication: US 2021/0228606
Methods for the Manufacture of Liposomal Drug Formulations
Application: 17/052,070 →
Publication: US 2021/0113467
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Application: 17/170,641 →
Publication: US 2021/0238152
Systems for Treating Pulmonary Infections
Application: 17/175,317 →
Publication: US 2021/0369752
Prostacyclin Compounds, Compositions and Methods of Use Thereof
Application: 17/186,658 →
Publication: US 2021/0276940
Sustained Release of Antiinfectives
Application: 17/197,867 →
Publication: US 2022/0016150
Deimmunized Lysostaphin and Methods of Use
Application: 17/199,484 →
Publication: US 2021/0395713
Lipo-Glycopeptide Cleavable Derivatives and Uses Thereof
Application: 17/295,360 →
Publication: US 2022/0024980
Glycopeptide Derivative Compounds and Uses Thereof
Application: 17/295,370 →
Publication: US 2021/0388028
Lipo-Glycopeptide Cleavable Derivatives and Uses Thereof
Application: 17/344,322 →
Publication: US 2022/0133843
Methods of Manufacturing Treprostinil and Treprostinil Derivative Prodrugs
Application: 17/470,723 →
Publication: US 2022/0135513
Unglycosylated Lysostaphin Variant Protein
Application: 17/480,166 →
Publication: US 2022/0213460
Aerosol Generator
Application: 17/504,654 →
Publication: US 2022/0088630
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides for Treating Bronchiectasis
Application: 17/576,470 →
Publication: US 2022/0133737
Methods and Materials for Producing Recombinant Viruses in Eukaryotic Microalgae
Application: 17/668,123 →
Publication: US 2022/0282205
Methods for Treating Pulmonary Non-Tuberculous Mycobacterial Infections
Application: 17/845,688 →
Publication: US 2022/0395524
Methods for Treating Pulmonary Non-Tuberculous Mycobacterial Infections
Application: 17/883,491 →
Publication: US 2023/0330119
Dry Powder Compositions of Treprostinil Prodrugs and Methods of Use Thereof
Application: 17/893,991 →
Publication: US 2022/0409537
Sustained Release of Antiinfectives
Application: 17/930,931 →
Publication: US 2023/0008563
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Application: 17/942,106 →
Publication: US 2023/0069044
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Application: 17/942,111 →
Publication: US 2023/0278969
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Application: 17/942,112 →
Publication: US 2023/0116721
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Application: 17/942,120 →
Publication: US 2023/0025351
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Application: 17/942,121 →
Publication: US 2023/0028726
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Application: 17/942,122 →
Publication: US 2023/0085620
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Application: 17/942,123 →
Publication: US 2023/0033573
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Application: 17/946,024 →
Publication: US 2023/0062646
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Application: 17/946,112 →
Publication: US 2023/0115170
Certain N-(1-Cyano-2-Phenylethyl)-1,4-Oxazepane-2-Carboxamides for Treating Cancer
Application: 63/234,961 →
Adeno-Associated Virus Vectors and Methods of Use and Delivery Thereof
Application: 63/239,881 →
Certain N-(1-Cyano-2-Phenylethyl)-1,4-Oxazepane-2-Carboxamides for Treating Cancer
Application: 63/241,754 →
Certain N-(1-Cyano-2-Phenylethyl)-1,4-Oxazepane-2-Carboxamides for Treating Chronic Rhinosinusitis
Application: 63/273,540 →
Dry Powder Compositions of Bedaquiline and Salts and Methods of Use Thereof
Application: 63/307,373 →
Certain N-(1-Cyano-2-Phenylethyl)-1,4-Oxazepane-2-Carboxamides for Treating Hidradenitis Suppurativa
Application: 63/310,751 →
Novel DPP1 Inhibitors and Uses Thereof
Application: 63/369,750 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger Jun 15, 2012
From: RIVER ACQUISITION CO.
To: TRANSAVE, INC.
Reel/Frame 028385/0357 →
Assignment of Assignor's Interest Jun 15, 2012
From: TRANSAVE, LLC
To: INSMED INCORPORATED
Reel/Frame 028385/0474 →
Merger Jun 15, 2012
From: TRANSAVE, INC.
To: TRANSAVE, LLC
Reel/Frame 028385/0433 →
Assignment of Assignor's Interest Aug 7, 2013
From: TRANSAVE, LLC
To: INSMED INCORPORATED
Reel/Frame 030959/0682 →
Assignment of Assignor's Interest Aug 7, 2013
From: BONI, LAWRENCE T.; MILLER, BRIAN S.; MALININ, VLADIMIR; LI, XINGONG
To: TRANSAVE, INC.
Reel/Frame 030958/0277 →
Merger Aug 7, 2013
From: TRANSAVE, INC.
To: TRANSAVE, LLC
Reel/Frame 030959/0547 →
Corrective Assignment to Correct the Name of the Assignor and the Assignee on the Cover Sheet Previously Recorded on Reel 027325 Frame 0401. Assignor(S) Hereby Confirms the Name of the Assignor Is Transave, Inc. and the Name of the Assignee Is Transave, Llc. Aug 7, 2013
From: TRANSAVE, INC.
To: TRANSAVE, LLC
Reel/Frame 030984/0214 →
Merger Aug 21, 2013
From: TRANSAVE, INC.
To: TRANSAVE, LLC
Reel/Frame 031051/0980 →
Assignment of Assignor's Interest Dec 3, 2013
From: TRANSAVE, LLC
To: INSMED INCORPORATED
Reel/Frame 031704/0669 →
Corrective Assignment to Correct the Receiving Party Street Address Previously Recorded at Reel: 038947 Frame: 0075. Assignor(S) Hereby Confirms the Assignment. Jul 1, 2016
From: TRANSAVE, LLC
To: INSMED INCORPORATED
Reel/Frame 039235/0465 →
Merger Aug 12, 2021
From: TRANSAVE, INC.
To: TRANSAVE, LLC
Reel/Frame 057162/0398 →
Assignment of Assignor's Interest Aug 12, 2021
From: BONI, LAWRENCE T.; MILLER, BRIAN S.; MALININ, VLADIMIR
To: TRANSAVE, INC.
Reel/Frame 057162/0137 →
Merger Aug 12, 2021
From: TRANSAVE, INC.
To: TRANSAVE, LLC
Reel/Frame 057162/0462 →
Assignment of Assignor's Interest Nov 2, 2021
From: TRANSPORIN, INC
To: ENMODULIN, INC
Reel/Frame 058769/0528 →
Assignment of Assignor's Interest Dec 15, 2021
From: MANGE, KEVIN; YUEN, DAYTON; JUMADILOVA, ZHANNA
To: INSMED INCORPORATED
Reel/Frame 058399/0234 →
Assignment of Assignor's Interest Jan 12, 2022
From: DU, JU; PLAUNT, ADAM; MALININ, VLADIMIR; PARIKH, MAULIKKUMAR
To: INSMED INCORPORATED
Reel/Frame 058626/0681 →
Assignment of Assignor's Interest May 13, 2022
From: TEPER, ARIEL; VERGARA, MARCELA MARTHA; USANSKY, HELEN HUI; MAES, ANDREA LYNN
To: INSMED INCORPORATED
Reel/Frame 059906/0449 →
Assignment of Assignor's Interest May 23, 2022
From: KONICEK, DONNA M.; GHARSE, SACHIN; PLAUNT, ADAM J.; SABNIS, ARMUTA
To: INSMED INCORPORATED
Reel/Frame 059992/0735 →
Assignment of Assignor's Interest May 23, 2022
From: PLAUNT, ADAM; MALININ, VLADIMIR
To: INSMED INCORPORATED
Reel/Frame 059992/0669 →
Assignment of Assignor's Interest May 23, 2022
From: PERKINS, WALTER R.; ROSE, SASHA
To: INSMED INCORPORATED
Reel/Frame 059992/0651 →
Assignment of Assignor's Interest May 23, 2022
From: ZHANG, JIMIN
To: INSMED INCORPORATED
Reel/Frame 059992/0583 →
Assignment of Assignor's Interest May 23, 2022
From: BASSO, JESSICA; ZHANG, JIMIN; CIPOLLA, DAVID
To: INSMED INCORPORATED
Reel/Frame 059992/0557 →
Assignment of Assignor's Interest May 23, 2022
From: CHEN, KUAN-JU; ZHANG, JIMIN; CIPOLLA, DAVID
To: INSMED INCORPORATED
Reel/Frame 059992/0499 →
Assignment of Assignor's Interest Jun 13, 2022
From: TEPER, ARIEL; VERGARA, MARCELA MARTHA; USANSKY, HELEN HUI; MAES, ANDREA LYNN
To: INSMED INCORPORATED
Reel/Frame 060175/0335 →
Assignment of Assignor's Interest Oct 11, 2022
From: SHALER, TONI
To: INSMED INCORPORATED
Reel/Frame 061383/0220 →